NPORT-EX 2 QTLY_505_20201130.htm

Quarterly Holdings Report
for

Fidelity® Select Portfolio®

Health Care Services Portfolio

November 30, 2020







MED-QTLY-0121
1.810676.116





Schedule of Investments November 30, 2020 (Unaudited)

Showing Percentage of Net Assets

Common Stocks - 97.3%   
 Shares Value 
Diversified Consumer Services - 1.1%   
Specialized Consumer Services - 1.1%   
Service Corp. International 258,000 $12,549,120 
Diversified Financial Services - 0.7%   
Other Diversified Financial Services - 0.7%   
Jaws Acquisition Corp. (a) 647,800 7,404,354 
Health Care Providers & Services - 89.5%   
Health Care Distributors & Services - 4.8%   
AmerisourceBergen Corp. 403,900 41,646,129 
McKesson Corp. 60,553 10,894,090 
  52,540,219 
Health Care Facilities - 6.2%   
Brookdale Senior Living, Inc. (a) 2,379,900 10,090,776 
HCA Holdings, Inc. 133,600 20,054,696 
Surgery Partners, Inc. (a)(b) 617,300 15,080,639 
U.S. Physical Therapy, Inc. 191,100 20,298,642 
Universal Health Services, Inc. Class B 21,200 2,768,296 
  68,293,049 
Health Care Services - 31.9%   
1Life Healthcare, Inc. (a)(b) 683,436 22,464,541 
Alignment Healthcare Partners unit (c)(d) 181,539 2,712,011 
Amedisys, Inc. (a) 175,200 42,887,208 
Andlauer Healthcare Group, Inc. 45,700 1,402,635 
BioScrip, Inc. (a) 262,200 4,129,650 
Chemed Corp. 86,200 41,225,150 
Cigna Corp. 621,672 130,016,482 
CVS Health Corp. 479,000 32,471,410 
LHC Group, Inc. (a) 204,196 40,087,759 
Oak Street Health, Inc. (a) 55,100 2,599,067 
Oak Street Health, Inc. 209,227 9,375,776 
Quest Diagnostics, Inc. 168,000 20,828,640 
  350,200,329 
Managed Health Care - 46.6%   
Anthem, Inc. 152,302 47,445,119 
Centene Corp. (a) 1,032,550 63,656,708 
Humana, Inc. 210,000 84,109,200 
Molina Healthcare, Inc. (a) 250,700 51,175,391 
UnitedHealth Group, Inc. 789,650 265,590,881 
  511,977,299 
TOTAL HEALTH CARE PROVIDERS & SERVICES  983,010,896 
Health Care Technology - 2.7%   
Health Care Technology - 2.7%   
Change Healthcare, Inc. (a) 1,314,034 22,509,402 
GoodRx Holdings, Inc. (b) 81,200 3,061,240 
Phreesia, Inc. (a) 55,805 2,464,349 
Teladoc Health, Inc. (a)(b) 11,729 2,331,373 
  30,366,364 
Insurance - 3.3%   
Insurance Brokers - 3.3%   
eHealth, Inc. (a) 211,700 16,087,083 
GoHealth, Inc. (a)(b) 1,255,500 13,232,970 
Selectquote, Inc. (b) 317,000 6,799,650 
  36,119,703 
TOTAL COMMON STOCKS   
(Cost $492,124,665)  1,069,450,437 
Money Market Funds - 6.1%   
Fidelity Cash Central Fund 0.09% (e) 23,553,807 23,558,518 
Fidelity Securities Lending Cash Central Fund 0.09% (e)(f) 42,848,767 42,853,052 
TOTAL MONEY MARKET FUNDS   
(Cost $66,411,570)  66,411,570 
TOTAL INVESTMENT IN SECURITIES - 103.4%   
(Cost $558,536,235)  1,135,862,007 
NET OTHER ASSETS (LIABILITIES) - (3.4)%  (37,102,188) 
NET ASSETS - 100%  $1,098,759,819 

Legend

 (a) Non-income producing

 (b) Security or a portion of the security is on loan at period end.

 (c) Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $2,712,011 or 0.2% of net assets.

 (d) Level 3 security

 (e) Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.

 (f) Investment made with cash collateral received from securities on loan.

Additional information on each restricted holding is as follows:

Security Acquisition Date Acquisition Cost 
Alignment Healthcare Partners unit 2/28/20 $2,200,001 

Affiliated Central Funds

Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:

Fund Income earned 
Fidelity Cash Central Fund $14,262 
Fidelity Securities Lending Cash Central Fund 93,770 
Total $108,032 

Amounts in the income column in the above table include any capital gain distributions from underlying funds. Amount for Fidelity Securities Lending Cash Central Fund represents the income earned on investing cash collateral, less rebates paid to borrowers and any lending agent fees associated with the loan, plus any premium payments received for lending certain types of securities.

Investment Valuation

Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fair Value Committee (the Committee) established by the Fund's investment adviser. In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund’s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:

Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy. 

Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.

For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.





The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.

Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.